| Announce Date | 12/11/2025 |
| EPS Normalized Actual | $-0.72 (Miss by $-0.02) |
| EPS GAAP Actual | $-0.72 (Miss by $-0.02) |
| Revenue Actual | $0.150166B |
| Revenue Surprise | Beat by $150.166M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2030 | 2.28 | 5.8 | 2.19612 | 2.39804 | 1 |
| Jan 2030 | 2.44 | 5.42 | 2.39676 | 2.51933 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.72 | -0.72 | 0.150166B | 0.17% | 150.17M |
| FQ3 2025 (Aug 2025) | -0.45 | -0.45 | 0.16053B | 2.45% | 160.53M |
| FQ2 2025 (May 2025) | -0.73 | -0.73 | 0.138373B | 4.14% | 138.37M |
| FQ1 2025 (Feb 2025) | 2.31 | 2.31 | 0.24149B | -3.73% | 241.49M |
| FQ4 2024 (Nov 2024) | -0.32 | -0.32 | 0.149905B | 100% | 149.91M |
| FQ3 2024 (Aug 2024) | -0.38 | -0.38 | 0.15659B | 100% | 156.59M |
| FQ2 2016 (Apr 2016) | -0.58 | -0.58 | 0.0152618B | 100% | 15.26M |
| FQ3 2016 (Jul 2016) | -0.58 | -0.58 | 0.0152618B | 100% | 15.26M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | -0.79 | -- | -0.80183 | -0.77198 | 1 |
| FQ3 2027 (Aug 2027) | -0.62 | -- | -0.62928 | -0.60586 | 1 |
| FQ2 2027 (May 2027) | -1 | -- | -1.01497 | -0.97719 | 1 |
| FQ1 2027 (Feb 2027) | 2.328 | -- | 2.28202 | 2.36147 | 1 |
| FQ4 2026 (Nov 2026) | -0.624 | -15.38 | -0.63297 | -0.61168 | 1 |
| FQ3 2026 (Aug 2026) | -0.422 | -6.64 | -0.42807 | -0.41367 | 1 |
| FQ2 2026 (May 2026) | -0.812 | 10.1 | -0.82367 | -0.79596 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0.17B | -- | 0.17B | 0.18B | 1 |
| FQ3 2027 (Aug 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
| FQ2 2027 (May 2027) | 0.16B | -- | 0.16B | 0.17B | 1 |
| FQ1 2027 (Feb 2027) | 0.26B | -- | 0.26B | 0.26B | 1 |
| FQ4 2026 (Nov 2026) | 0.16B | 5.15 | 0.16B | 0.16B | 2 |
| FQ3 2026 (Aug 2026) | 0.17B | 4.82 | 0.17B | 0.17B | 2 |
| FQ2 2026 (May 2026) | 0.14B | 4.21 | 0.14B | 0.15B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.72 | -0.72 | 100% | |
| FQ3 2025 (Aug 2025) | -0.45 | -0.45 | 100% | |
| FQ2 2025 (May 2025) | -0.73 | -0.73 | 100% | |
| FQ1 2025 (Feb 2025) | 2.31 | 2.31 | 100% | |
| FQ4 2024 (Nov 2024) | -0.32 | -0.32 | 100% | |
| FQ3 2024 (Aug 2024) | -0.38 | -0.38 | 100% | |
| FQ2 2016 (Apr 2016) | -0.58 | -0.58 | 100% | |
| FQ3 2016 (Jul 2016) | -0.58 | -0.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.15B | $150.17M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.16B | $160.53M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.14B | $138.37M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.24B | $241.49M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.15B | $149.91M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.16B | $156.59M | 100% |
| FQ2 2016 (Apr 2016) | $0B | $0.02B | $15.26M | 100% |
| FQ3 2016 (Jul 2016) | $0B | $0.02B | $15.26M | 100% |